A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

7.7K views

⸱

DOI:

10.3791/51903

⸱

October 21st, 2014

 ,  ,  , 

In This Article

Summary

Globoid cells are a defining pathological feature of Krabbe disease, a leukodystrophy currently lacking an effective long-term therapy. We have developed a cell culture model to study the innate biology and pathogenic potential of activated microglia and their transformation into globoid cells.

Abstract

The precise function of multi-nucleated microglia, called globoid cells, that are uniquely abundant in the central nervous system of globoid cell leukodystrophy (GLD) is unclear. This gap in knowledge has been hindered by the lack of an appropriate in vitro model for study. Herein, we describe a primary murine glial culture system in which treatment with psychosine results in multinucleation of microglia resembling the characteristic globoid cells found in GLD. Using this novel system, we defined the conditions and modes of analysis for study of globoid cells. The potential use of this model system was validated in our previous study, which identified a potential role for matrix metalloproteinase (MMP)-3 in GLD. This novel in vitro system may be a useful model in which to study the formation and function, but also the potential therapeutic manipulation, of these unique cells.

Introduction

Globoid cell leukodystrophy (GLD), also known as Krabbe disease, is a fatal demyelinating disease resulting from loss of function mutations in the galatocerebrosidase (galc) gene1. The most prevalent form of GLD is the infantile variant which is typified by onset in early childhood and characterized by an aggressive clinical course of motor and cognitive decline leading to premature death often before five years of age2,3. Genetic testing is used to verify a diagnosis of GLD4. Neuropathology of GLD reveals widespread demyelination, neuronal atrophy, astrogliosis and presence of engorged multi-nucleated microglia called globoid cells

Access restricted. Please log in or start a trial to view this content.

Protocol

All procedures involving animals were performed in accordance with the Policy on Humane Care and Use of Laboratory Animals set forth by the Office of Laboratory Animal Welfare (NIH) and only with approval from the Institutional Animal Care and Use Committee (IACUC) of the University of Connecticut Health Center.

1. Preparation of Mixed Glial Cultures

  1. Sterilize all instruments prior to use. Add 3 ml of ice-cold sterile Hank’s balanced salt solution (HBSS) containing no cations (Mg2+ or Ca2+) to three sterile 60 mm Petri dishes maintained on ice to keep cold.
  2. Isolate the cortices from postnata....

Access restricted. Please log in or start a trial to view this content.

Results

This protocol, as written, is expected to take approximately 36 days to complete from start to finish (See Figure 1: Experimental Workflow Scheme). It has been our experience that the development of 'globoid-like' cells in this primary culture system is both reliable and reproducible: the formation of multinucleated cells in response to psychosine is consistently observed with 7 days of treatment.

Immunocytochemical staining of microglia using Iba-1 in conjunction with a nucle.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The protocol described herein provides a new model system in which to study the development and functional characterization of activated microglia and globoid cells. Prior work by Im et al. using a HEK293 cell line provided a template for the development of the present protocol for the study of globoid cell formation21. It is also important to point out that the globoid cells derived in the model differ from the native globoid cells identifiable in GLD. For instance, we have routinely observed quadran.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no conflicts of interest.

Acknowledgements

This work was supported in part by grants from the National Multiple Sclerosis Society (RG 5001-A-3 to S.J.C.), the National Institutes of Health (NS065808 to E.R.B.; NS078392 to S.J.C.), start-up funds from the UConn Health Center (to SJC) and the Kim Family Fund (UCHC in support of K.I.C.).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Hank’s balanced salt solution (HBSS) containing no cations (Mg2+ and Ca2+).Life technologies14175-095
Neural Tissue Dissociation KitMiltenyi130-092-628
40 μm cell-strainerFisherbrand22363547
Hank’s balanced salt solution (HBSS) containing cations (Mg2+ and Ca2+).Gibco14025-092
Dulbecco's modified eagle medium (DMEM)Gibco11995-065
fetal bovine serum (FBS)Atlanta BiologicalsS11150
Penicilin/StreptomycinLife technologies15070-063
LamininSigmaL2020
Trypsin-EDTA solutionLife technologies25299-056
PsychosineSigmaP9256
Dimethyl sulfoxide (DMSO)SigmaD2650
Paraformaldehyde (PFA)Electron Microscopy Science19208
Normal Goat Serum (NGS)InvitrogenPCN5000
Iba-1WAKO019-19741
Alexa Fluor conjugated antiseraLife TechnologiesVarious
Mounting MediaSouthern BiotechOB100-01
Phagocytic Assay KitCayman Chemicals500290
HEPESSigmaBP310-500

References

  1. Rafi, M. A., Luzi, P., Chen, Y. Q., Wenger, D. A. A large deletion together with a point mutation in the GALC gene is a common mutant allele in patients with infantile Krabbe disease. Hum Mol Genet. 4, 1285-1289 (1995).
  2. Duffner, P. K., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Primary Glial CultureCycline TreatmentMicroglia MultinucleationImmunofluorescent MicroscopyECM Coated Cover SlipsPhagocytic Activity AssessmentIO One Microglia MarkerFluorescent Microscopy AnalysisOligodendrocyte Progenitor Cells